Review
doi: 10.1016/j.cld.2006.08.026.
The economics of hepatitis C virus
Affiliations
- PMID: 17164114
- DOI: 10.1016/j.cld.2006.08.026
Item in Clipboard
Review
The economics of hepatitis C virus
Clin Liver Dis.
2006 Nov.
Abstract
Hepatitis C virus is a disease of major public health significance throughout the world in terms of overall morbidity and mortality and in its economic consequences and demands on medical resources. The global economic burden of this disease has yet to be fully realized. In this article the authors discuss the economic burden of hepatitis C, the economics of therapy, and the economics of its prevention and screening.
Similar articles
-
Is there discrimination in access to therapy for HCV patients?J Hepatol. 2008 Oct;49(4):491-3. doi: 10.1016/j.jhep.2008.07.003. Epub 2008 Jul 18. J Hepatol. 2008. PMID: 18678432 No abstract available.
-
Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):76-8. doi: 10.1038/nrgastro.2012.247. Epub 2013 Jan 8. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23296251 Review. No abstract available.
-
Cost effectiveness evaluation of hepatitis C therapy in Lahore.Pak J Pharm Sci. 2017 Nov;30(6):2233-2237. Pak J Pharm Sci. 2017. PMID: 29175794
-
Economic impact of extended treatment with peginterferon alpha-2a and ribavirin for slow hepatitis C virologic responders.J Viral Hepat. 2008 Apr;15(4):293-9. doi: 10.1111/j.1365-2893.2007.00943.x. J Viral Hepat. 2008. PMID: 18307591
-
A pharmacoeconomic appraisal of therapies for hepatitis B and C.Expert Opin Pharmacother. 2001 Feb;2(2):205-11. doi: 10.1517/14656566.2.2.205. Expert Opin Pharmacother. 2001. PMID: 11336580 Review.
Cited by
-
Impact of new therapeutics for hepatitis C virus infection in incarcerated populations.Top Antivir Med. 2013 Feb-Mar;21(1):27-35. Top Antivir Med. 2013. PMID: 23596276 Free PMC article. Review.
-
Challenges Facing Viral Hepatitis C Elimination in Lebanon.Pathogens. 2023 Mar 9;12(3):432. doi: 10.3390/pathogens12030432. Pathogens. 2023. PMID: 36986354 Free PMC article. Review.
-
Hepatitis C: a clinical review.Oral Dis. 2008 Jan;14(1):10-4. doi: 10.1111/j.1601-0825.2007.01419.x. Oral Dis. 2008. PMID: 18173443 Free PMC article. Review.
-
Direct medical care costs among pegylated interferon plus ribavirin-treated and untreated chronic hepatitis C patients.Dig Dis Sci. 2011 Oct;56(10):3024-31. doi: 10.1007/s10620-011-1802-z. Epub 2011 Jun 30. Dig Dis Sci. 2011. PMID: 21717127
-
Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.Virol J. 2011 Sep 21;8:445. doi: 10.1186/1743-422X-8-445. Virol J. 2011. PMID: 21936899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
